FDA.reportPublic FDA data

Killa Extra Strength

Manufacturer
Zitsticka, Inc. | Raphas
Effective date
2023-06-16
Label type
HUMAN OTC DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-05-31 23:55:16

Label at a glance#

ProductKilla Acne Extra Strength
Active ingredientSALICYLIC ACID
Label structure10 sections

Indications and uses

Uses: For the management of acne. Penetrates pores to eliminate most blemishes

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Ask a doctor

OTC - ASK DOCTOR SECTION

If irritation becomes severe

When using this product

OTC - WHEN USING SECTION

Skin irritation and dryness may occur if you use another topical acne medication at the same time or immediately following. If irritation occurs, only use one topical acne medication at a time unless directed by a doctor.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Posion Control Center right away.

NA

DOSAGE & ADMINISTRATION SECTION

NA

Warnings

WARNINGS SECTION

For extrernal use only

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Inactive Ingredients:

Sodium Hyaluronate, Phytosphingosine HCL, Niacinamide, Oligopeptide-10, Glycolic Acid, Madecassoside, 4-Butylresorcinol.

Patch: Hydrocolloid

Uses

INDICATIONS & USAGE SECTION

Uses:

  • For the management of acne.
  • Penetrates pores to eliminate most blemishes

Killa Acne ES PDP

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

KAES 4 Pack PDPKAES 4 Pack PDP

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1546588salicylic acid 2 % Medicated PatchPSN7
1546588salicylic acid 0.02 MG/MG Medicated PatchSCD7
1546588salicylic acid 2 % Medicated PatchSY7

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
81746-420-012025-01-30C16284748780-12cef2736-a231-d83d-e063-dadaa90ab31ff05acefe-1462-32f2-e053-2a95a90a959e

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81746-420-01Killa Acne Extra Strength3220 mg in 1 BOXPATCH32207

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81746-420KILLA ACNE EXTRA STRENGTH (SALICYLIC ACID) PATCH [ZITSTICKA, INC.]71 package rows20230617_f05acefe-1462-32f2-e053-2a95a90a959e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81746-42081746-420-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
NameUNIIKind
OLIGOPEPTIDE-10Q46328TRNKIACT
NIACINAMIDE25X51I8RD4IACT
GLYCOLIC ACID0WT12SX38SIACT
4-BUTYLRESORCINOL2IK4UQ3ZGAIACT
SALICYLIC ACIDO414PZ4LPZACTIB
HYALURONATE SODIUMYSE9PPT4THIACT
MADECASSOSIDECQ2F5O6YIYIACT
PHYTOSPHINGOSINE HYDROCHLORIDETT871XV7TUIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
fe3f5807-cd71-52d2-e053-6294a90a21c6f05acefe-1462-32f2-e053-2a95a90a959e2023-06-16WarningsExact identifier
spl id: fe3f5807-cd71-52d2-e053-6294a90a21c6
spl set id: f05acefe-1462-32f2-e053-2a95a90a959e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.